CBCardoso Borges

Cardoso Borges

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cardoso Borges has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Photobiomodulation by infrared radiation on hallmarks of cancer

    by da Silva Ferreira, Ana Caroline, Thayssa Gomes Farias, Cardoso Borges, Ana Julia, Marcelle Abreu da Silva, Barreto Pires, Bruno Ricardo, Andre Luiz Mencalha, Adenilson de Souza da Fonseca

    Photobiomodulation (PBM) is a therapeutic technique that utilizes non-ionizing radiation, such as infrared radiation, which is capable of stimulating or inhibiting biological processes. Cancer is characterized by uncontrolled cell growth and proliferation in any body structure, allowing it to invade other tissues. Cancer exhibits distinct biological characteristics, the so-called hallmarks of cancer. Despite the therapeutic benefits of PBM, and cancers affect millions of people worldwide, the mechanisms involved in PBM, as those induced by infrared A radiation, on cancer are not yet fully elucidated. Thus, we aimed to review the effects of PBM induced by infrared radiation on the hallmarks of cancer. For this, studies on the effects of PBM induced by infrared A radiation on in vitro and in vivo experimental models of cancer were accessed via MEDLINE/PubMed. The data accessed showed that effects of PBM induced by infrared A radiation were evaluated on four hallmarks of cancer (sustaining proliferative signaling, evading growth suppressors, genomic instability and mutation, and resisting cell death) but not on the other ten ones (enabling replicative immortality, non-mutational epigenetic reprogramming, avoiding immune destruction, tumor-promoting inflammation, polymorphic microbiomes, activating invasion and metastasis, inducing or accessing vasculature, senescent cells, deregulation cellular energetics, unlocking phenotypic plasticity). Thus, considering the therapeutic benefits of PBM, evaluation of the effects of PBM on the hallmarks of cancer can also bring such benefits to oncologic patients.


  • Could photobiomodulation be used for treatment of rosacea?

    by Boaretto Netto, José Carlos, Cardoso Borges, Ana Julia, Thayssa Gomes Farias, Adenilson de Souza da Fonseca

    Rosacea is a chronic inflammatory disease characterized by facial skin lesions, including flushing, persistent erythema, papules, telangiectasia, and phymatous changes, affecting 5.5% of the world’s population. Rosacea causes disfigurement and emotional ramifications and affects quality of life. The pathophysiology of this disease has yet to be understood, and new therapies are necessary. Photobiomodulation has been used to treat dermatological diseases and various conditions, such as inflammatory processes and pain relief. Thus, this study aimed to review studies on PBM for rosacea treatment, summarizing the radiation sources and subject features and reporting the main results. Scientific articles were accessed by PubMed, using keywords related to rosacea and photobiomodulation. Data on irradiation conditions, patient features, experimental models, and results obtained were assessed. The data analysis allowed to list the conditions for applying photobiomodulation that could lead to therapeutic effects, safety, and efficacy in treating the rosacea. Based on clinical and experimental studies accessed, photobiomodulation could decrease rosacea hallmarks and symptoms by decreasing of pro-inflammatory factor expression, inflammatory infiltration and immune cells, and promoting extracellular matrix remodeling. However, due to few studies available on the application of photobiomodulation in the treatment of rosacea, studies based on experimental and clinical models are necessary to better understand the mechanisms of action of this therapy, efficacy, and validation in the treatment of rosacea.